Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Obeid

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Current Cardiology Reports|July 3, 2026
Cardioimmunology of Myocarditis: Targeting the IL-1 PathwayEmanuele Chiara, Maurizio Pieroni, Michel Obeid, et al.
Journal for Immunotherapy of Cancer|October 24, 2018
A severe case of neuro-Sjögren's syndrome induced by pembrolizumabJaqueline Ghosn, Alex Vicino, Olivier Michielin, et al.
International Journal of Molecular Sciences|July 29, 2023
Neoadjuvant Immunotherapy: A Promising New Standard of CareEmma Boydell, Jose L Sandoval, Olivier Michielin, et al.
Cancer Treatment Reviews|August 21, 2023
Novel targets for immune-checkpoint inhibition in cancerMaxime Borgeaud, Jose Sandoval, Michel Obeid, et al.
Haematologica|September 8, 2022
Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trialGrégoire Stalder, Madeleine Suffiotti, Amandine Segot, et al.
Frontiers in Immunology|August 25, 2023
A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cellsVictor Joo, Constantinos Petrovas, Laurence de Leval, et al.
Journal for Immunotherapy of Cancer|December 28, 2018
A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapyAlice Horisberger, Stefano La Rosa, Jean-Philippe Zurcher, et al.
Journal for Immunotherapy of Cancer|June 28, 2023
Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapiesRita Godinho, Alessandra Noto, Craig Fenwick, et al.
Cancer Genomics & Proteomics|September 7, 2007
Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cellsLionel Apetoh, Michel Obeid, Antoine Tesniere, et al.
Cancer Research|September 7, 2007
Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenicMichel Obeid, Theocharis Panaretakis, Antoine Tesniere, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Current Cardiology Reports|July 3, 2026
Cardioimmunology of Myocarditis: Targeting the IL-1 PathwayEmanuele Chiara, Maurizio Pieroni, Michel Obeid, et al.
Journal for Immunotherapy of Cancer|October 24, 2018
A severe case of neuro-Sjögren's syndrome induced by pembrolizumabJaqueline Ghosn, Alex Vicino, Olivier Michielin, et al.
International Journal of Molecular Sciences|July 29, 2023
Neoadjuvant Immunotherapy: A Promising New Standard of CareEmma Boydell, Jose L Sandoval, Olivier Michielin, et al.
Cancer Treatment Reviews|August 21, 2023
Novel targets for immune-checkpoint inhibition in cancerMaxime Borgeaud, Jose Sandoval, Michel Obeid, et al.
Haematologica|September 8, 2022
Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trialGrégoire Stalder, Madeleine Suffiotti, Amandine Segot, et al.
Frontiers in Immunology|August 25, 2023
A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cellsVictor Joo, Constantinos Petrovas, Laurence de Leval, et al.
Journal for Immunotherapy of Cancer|December 28, 2018
A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapyAlice Horisberger, Stefano La Rosa, Jean-Philippe Zurcher, et al.
Journal for Immunotherapy of Cancer|June 28, 2023
Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapiesRita Godinho, Alessandra Noto, Craig Fenwick, et al.
Cancer Genomics & Proteomics|September 7, 2007
Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cellsLionel Apetoh, Michel Obeid, Antoine Tesniere, et al.
Cancer Research|September 7, 2007
Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenicMichel Obeid, Theocharis Panaretakis, Antoine Tesniere, et al.
Pageof 5